STOCK TITAN

Retractable Technologies, Inc - RVP STOCK NEWS

Welcome to our dedicated page for Retractable Technologies news (Ticker: RVP), a resource for investors and traders seeking the latest updates and insights on Retractable Technologies stock.

Retractable Technologies, Inc. (RVP) stands at the forefront of innovation in the healthcare industry, specializing in the design, development, manufacturing, and marketing of safety syringes and other essential medical products. With a commitment to reducing the global spread of infectious diseases, the company offers an array of products that ensure safe and efficient medical practices.

Among their flagship products are the VanishPoint series, which includes the 0.5mL insulin syringe, 1mL tuberculin, insulin, and allergy antigen syringes, and various sizes such as 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes. They also offer specialized items like the small diameter tube adapter, blood collection tube holder, allergy tray, IV safety catheter, Patient Safe syringes, Patient Safe Luer Cap, and the VanishPoint Blood Collection Set. Additionally, the EasyPoint needle and the standard 3mL syringe packaged with an EasyPoint needle further exemplify their dedication to safety and innovation.

Retractable Technologies is not just a manufacturer; it is a pioneer in the medical device industry, continually evolving to meet the needs of healthcare professionals worldwide. The company’s products, including the VanishPoint autodisable syringes, are also available in international markets, showcasing their global reach and influence.

Recent achievements highlight their ongoing contributions and advancements. The company remains financially robust, supported by steady demand and strategic partnerships. These collaborations align with their mission to build a model corporation that promotes performance, pride, and profit while setting a standard for excellence and integrity.

Retractable Technologies' vision extends beyond product development to encompass education and safe medical practices. This holistic approach ensures that they are a catalyst in the fight against infectious diseases, fostering a safer environment for patients and healthcare providers alike.

Rhea-AI Summary

Retractable Technologies, Inc. (RVP) announced dividends for Series II Class B and Series III Class B Convertible Preferred Stock, amounting to $39,050.00 and $19,061.25 respectively. The dividends, accrued at $1.00 per share per annum, cover the period from January 1, 2022, to March 31, 2022. Payment is scheduled for April 21, 2022, to shareholders of record as of April 11, 2022. The company specializes in safety medical products designed to reduce needlestick injuries and bloodstream infection risks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
dividends
-
Rhea-AI Summary

Retractable Technologies, Inc. (RVP) declared dividends for its Series II Class B and Series III Class B Convertible Preferred Stock totaling $39,050.00 and $39,495.10. The dividends accrued at $1.00 per share per annum. The Series II dividends cover October 1, 2021, to December 31, 2021, while the Series III dividends cover July 1, 2021, to December 31, 2021. Payment is scheduled for January 24, 2022, to shareholders of record as of January 10, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
dividends
-
Rhea-AI Summary

Retractable Technologies, Inc. (NYSE American: RVP) reported significant improvement in financial performance for the first nine months of 2021, with operating income rising to $44.1 million compared to $11.8 million in the previous year. Income applicable to common shareholders also surged to $35.0 million from $14.7 million. Net sales reached $36.4 million for Q3 2021, driven largely by orders from the U.S. government, which accounted for over 50% of total sales. Despite revenue increases, gross margins were pressured by rising transportation costs due to COVID-19 impacts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.26%
Tags
none
Rhea-AI Summary

Retractable Technologies, Inc. (NYSE American: RVP) has declared dividends of $39,050 for its Series II Class B Convertible Preferred Stock, equating to $0.25 per share. The accrued dividends at 10% per annum cover amounts from July 1, 2021 to September 30, 2021. Payment is scheduled for October 22, 2021, to shareholders on record as of October 12, 2021. This announcement highlights the company's commitment to its investors, despite potential operational risks and external market challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.32%
Tags
dividends
-
Rhea-AI Summary

Retractable Technologies, Inc. (NYSE American: RVP) reported a significant increase in operating income, reaching $36.1 million for the first six months of 2021, up from $1.4 million in the prior year. Income applicable to common shareholders was $28.5 million, compared to $3.7 million the previous year. Net sales for the quarter ended June 30, 2021, were $42.5 million, with the U.S. government accounting for 64.4% of sales. Domestic revenues surged 325.0%, driven by increased government orders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.63%
Tags
none
-
Rhea-AI Summary

Retractable Technologies, Inc. (RVP) has approved a stock repurchase plan for up to $10 million, starting June 18, 2021. This plan will run until June 18, 2022, and is designed to enhance shareholder value in response to the stock's perceived undervaluation. The company will also distribute $5,056,945 in dividends to its Class B Convertible Preferred shareholders, including amounts in arrears, with payments scheduled for July 22, 2021. CEO Thomas J. Shaw acknowledged shareholder patience and highlighted the company's commitment to providing essential safety products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.82%
Tags
buyback dividends
Rhea-AI Summary

Retractable Technologies, Inc. (RVP) announced an amendment to delivery order 75A50120F33003 from the Department of Health and Human Services, extending the performance end date from May 2021 to March 2022. The amendment reallocates orders to increase shipments of 1mL low dead-space safety syringes. The total contract price and freight costs remain unchanged. The company emphasizes potential challenges, including COVID-19 impacts, liquidity issues, and foreign trade risks among others, that could affect future performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.13%
Tags
none
-
Rhea-AI Summary

Retractable Technologies, Inc. (NYSE American: RVP) has received preliminary notice from the U.S. Department of Health and Human Services to exercise all seven one-month option periods under contract 75A50121P00021, extending the contract's expiration to February 14, 2022. This extension increases the contract's value by $92,772,680, covering products and freight reimbursement costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.67%
Tags
none
-
Rhea-AI Summary

Retractable Technologies Inc. (NYSE American: RVP) has amended its Technology Investment Agreement with the U.S. government, securing an additional $27.4 million in funding. This increase aims to boost domestic manufacturing capabilities by at least 50% to meet ongoing COVID-19 countermeasure demands. The funding will be used to expand production of 1mL low dead-space safety syringes by adding new assembly lines and expanding facilities in Little Elm, Texas. The modification effort is scheduled to be completed by January 31, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
none
Rhea-AI Summary

Retractable Technologies, Inc. (NYSE American: RVP) reported a significant increase in operating income to $23.4 million for Q1 2021, a sharp rise from $481 thousand a year prior. U.S. government sales accounted for 75.5% of total revenues, highlighting a 484.7% increase in domestic sales. Additionally, the company had its $1.36 million PPP loan forgiven. However, operating expenses increased 50%, driven by higher headcount and related costs. Overall, domestic unit sales surged 282.6%, although international revenues decreased by $1.5 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.69%
Tags
none

FAQ

What is the current stock price of Retractable Technologies (RVP)?

The current stock price of Retractable Technologies (RVP) is $0.628 as of December 2, 2024.

What is the market cap of Retractable Technologies (RVP)?

The market cap of Retractable Technologies (RVP) is approximately 18.9M.

What products does Retractable Technologies, Inc. offer?

Retractable Technologies, Inc. offers safety syringes like VanishPoint, insulin syringes, blood collection sets, IV safety catheters, and EasyPoint needles.

What is the mission of Retractable Technologies, Inc.?

Their mission is to build a model corporation for employees, customers, community, and shareholders based on performance, pride, and profit.

Where can I find Retractable Technologies' products?

Their products are available both domestically and internationally, including the VanishPoint autodisable syringes.

What is the vision of Retractable Technologies, Inc.?

The company's vision is to reduce the worldwide spread of infectious diseases through innovation, education, and reliable medical devices.

How does Retractable Technologies contribute to global healthcare?

They provide innovative safety medical products designed to prevent the spread of infectious diseases, ensuring safer medical practices.

What recent achievements has Retractable Technologies made?

The company has made significant strides in product development and strategic partnerships, enhancing their market reach and financial stability.

What is unique about the VanishPoint syringes?

VanishPoint syringes feature automatic needle retraction to prevent needle-stick injuries, ensuring safety for healthcare professionals.

What is the EasyPoint needle?

The EasyPoint needle is a versatile needle option that enhances the safety and efficiency of medical procedures.

Does Retractable Technologies engage in any educational initiatives?

Yes, the company focuses on education alongside product innovation to promote safe medical practices globally.

How does Retractable Technologies ensure product quality?

They adhere to high standards of excellence, effectiveness, and integrity in developing and delivering their products.

Retractable Technologies, Inc

NYSE:RVP

RVP Rankings

RVP Stock Data

18.86M
13.09M
56.27%
8.07%
0.11%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
LITTLE ELM